This article focuses on recent trends and outcomes of bariatric surgery. The outcomes discussed include perioperative morbidity and mortality, weight loss, long-term complications and the impact of bariatric surgery on comorbidities, cardiovascular risk and mortality.
Introduction
The rising prevalence of obesity, along with high failure rates of non-operative weight-reduction programs, has led to the prosperity of bariatric surgery. [1] [2] [3] [4] It was recently estimated that close to 350 000 bariatric operations were performed worldwide in 2008. 5 With this increasing volume of bariatric cases and the availability of longer term followup, it is now possible to formulate a better assessment of outcomes after weight loss surgery. Evaluating outcomes from the various procedures enables informed decision making, patient-tailored procedure selection, identifies technical aspects of importance and helps the surgeon and patient to determine realistic outcome expectations. Significant metabolic impacts of these procedures have led to the understanding that much more than weight loss can be achieved, and many have embraced the term 'metabolic surgery' to emphasize this. These metabolic effects, which include resolution or improvement of metabolic syndrome, diabetes, hypertension and dyslipidemia, among others, are usually witnessed much before any significant weight loss has occurred, [6] [7] [8] implying contribution of different mechanisms, some of which are still elusive. Gastric banding, sleeve gastrectomy, Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD) with or without duodenal switch are the most commonly performed bariatric procedures at present ( Figure 1 ). Whereas banding and sleeve gastrectomy are purely restrictive in nature, the latter two procedures also result in significant malabsorption. The mechanism of action of each procedure results in unique outcomes and also contributes to a constellation of procedure-specific risks, merits and limitations. In this review, we summarize the published outcomes of commonly performed bariatric procedures, including weight loss, perioperative morbidity and mortality, late complications, as well as the impact of bariatric surgery on comorbidities, cardiovascular risk and mortality.
Current trends in bariatric procedures
Ongoing research and technological innovations have contributed greatly to the evolution and advancement of bariatric surgery. Over the last decade, in addition to novel combined/hybrid approaches, modifications of the traditional malabsorptive and restrictive procedures have emerged. Sleeve gastrectomy, initially considered as the first component of a two-stage procedure in high-risk patients, has been shown to be effective as a stand-alone bariatric procedure and is gaining popularity among bariatric surgeons. 9 In contrast, vertical banded gastroplasty was the prototype-restrictive operation for many years, until acknowledgment of its high failure rates and long-term complications resulted in it being largely abandoned. Currently, the two most popular procedures performed worldwide are gastric bypass and gastric banding, accounting for 49% and 42% of the total case volume, respectively.
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Sleeve gastrectomy, BPD and duodenal switch together account for o10% of all bariatric operations performed at present ( Figure 2 ). Regional variations exist with regard to preferences for individual procedures; although gastric bypass remains the most popular weight loss surgery in the United States, this preference was not shared by bariatric surgeons throughout the world, until recently. In Europe, trends suggest that the pendulum may be changing; gastric banding was the procedure of choice there for the last decade; however, in 2008, preference for adjustable gastric banding decreased from 63.7% to 43.2%, whereas RYGB increased from 11.1% to 39.0%.
Perioperative morbidity and mortality
Developments in surgical innovations and in the medical device industry, coupled with increasing experience in minimally invasive surgery over the past two decades, enable the majority of bariatric cases, prevalent currently, to be performed laparoscopically. 10, 11 Conversion rates to open surgery are in the range of 0-5.7%, with the highest rates observed in more complex malabsorptive procedures. [12] [13] [14] [15] Intraabdominal adhesions encountered during revisional bariatric surgery also predispose to a greater risk of failure for the laparoscopic approach. In the first systematic review and meta-analysis of published mortality data after bariatric surgery, Buchwald et al. 16 reported extremely low early and late mortality rates after bariatric procedures, 0.28 and 0.35%, respectively. Mortality rates were higher in cases requiring an open approach, primarily or being converted to open, in male patients and in the superobese. 16 The Longitudinal Assessment of Bariatric Surgery study, which determined the 30-day safety outcomes in patients undergoing a primary bariatric procedure, subsequently reported a similarly low perioperative mortality rate (0.3%) among 4776 patients. 17 With regard to perioperative morbidity, given the high-risk status of an obese and medically comorbid population, one may expect relatively high and even prohibitive operative morbidity rates. On the contrary, complication rates following bariatric surgery are quite acceptable; the Longitudinal Assessment of Bariatric Surgery study reported a 4.3% incidence of major adverse events in the early postoperative period. 17 Although these reports are encouraging, a number of complications associated with bariatric surgery are potentially fatal. These include sepsis from an anastomotic dehiscence, shock secondary to hemorrhage or cardiopulmonary events in this high-risk comorbid population. All obese surgical candidates have an increased risk for thromboembolic phenomena, and this is the leading cause of death following bariatric surgery, with an incidence of 0.34% according to the national analysis of adverse patient safety events in bariatric surgery. 18, 19 Mechanical and pharmacological prophylactic measures for deep vein thrombosis are therefore routinely practiced in order to reduce this risk. 20 Perhaps the most feared complication of bariatric surgery is gastrointestinal leak, with rates varying according to the procedure performed, ranging from 1%, for gastric banding, to 2%, for gastric bypass and sleeve gastrectomy. 9, 21, 22 The majority of leaks originate at staple lines or anastomotic sites; less frequently, iatrogenic bowel injuries are responsible. Early identification and an aggressive approach to management of leaks improve the outcome. Conservative management is only indicated for leaks that are controlled by a surgical drain, in a hemodynamically stable patient; otherwise, surgical exploration and management is prudent. Early bleeding episodes complicate 1-4% of bariatric surgeries, considering both intraluminal and intraperitoneal events. The majority of these can be treated non-operatively with volume resuscitation and transfusion of blood products, but close observation is crucial for early identification of hemodynamic instability necessitating surgical intervention.
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Late morbidity
Long-term complications of bariatric surgery are unique to the specific procedure. Restrictive operations, in which Surgery for obesity S Eldar et al a narrow passage is created either at the anastomosis or at the level of a band or staple line, are susceptible to stricture formation leading to partial or complete bowel obstruction either in the acute setting secondary to edema or in the long term due to fibrosis and scar tissue formation. Complicating up to 7% of laparoscopic RYGB cases, and usually presenting in the first postoperative month, these anastomotic strictures can often be managed endoscopically with balloon dilatations, rarely complicated by perforation. 26 Obstructive symptoms following gastric banding are usually the result of band slippage or overinflation, and are generally easily corrected by band adjustment in the clinic. Obstructive symptoms following sleeve gastrectomy usually present immediately following surgery, and may indicate an excessively 'tight' sleeve exacerbated by postoperative edema. As the edema resolves, symptom resolution usually ensues.
Another frequently reported delayed complication of bariatric surgery, usually presenting later in the postoperative course, is ulceration in proximity to the gastrojejunal anastomosis of a gastric bypass or BPD. These 'marginal ulcers' are consequent to exposure of the unprotected jejunal mucosa to gastric acidity, and the incidence is reported to be B7%. Medical treatment with proton-pump inhibitors is sufficient for the majority of cases, although there is a select group of patients who continue to suffer from symptomatic, non-healing ulcers, despite appropriate medical treatment, and who require surgical intervention. 27 Gastric band patients are inherently predisposed to developing band-related complications, including band slippage, band deflation (from ruptured balloon or inflation port breakage) and erosion, resulting in reintervention rates as high as 20%. 28 Band salvage procedures include endoscopic or laparoscopic removal of the band in case of erosion, laparoscopic repositioning in the event of band slippage or laparoscopic replacement of the band in the case of leakage. Incisional and internal herniation can complicate both open and laparoscopic bariatric procedures. The reported incidence for internal herniation is as high as 2.5-6.2%; given that presenting symptoms and clinical signs associated with this phenomenon may be subtle, and the potential for bowel ischemia leading to fatal consequences, a high index of suspicion is critical for early diagnosis and timely intervention. 29, 30 Abdominal computed tomography imaging is the most sensitive study for the identification of an internal hernia, often demonstrating the classic 'swirl' sign of the herniated bowel mesentery. 31 Surgical exploration, reduction of the hernia and resection of non-viable bowel is the mainstay of treatment. Special attention must always be given to the nutritional status of patients following malabsorptive bariatric procedures. Deficiency of essential vitamins and minerals is highly likely following RYGB and BPD, and on rare occasions may be life threatening, as seen with thiamine deficiency encephalopathy. The multidisciplinary team managing bariatric patients must be mindful of malabsorptive nutritional consequences, and dietary supplementation following the procedure is recommended, including chronic supplementation of vitamins D and B12, folic acid, iron and calcium, among others. 32 Scheduled surveillance of the above parameters by blood tests should be done on a regular basis, at 3-month intervals for the first postoperative year, and annually thereafter.
Weight loss
The primary goal of bariatric procedures is weight loss and while the various procedures achieve this to different extents, the overall percentage of excess weight loss (EWL) is reported to be as high as 47-70% in the long term. 6 Malabsorptive procedures such as RYGB and BPD achieve greater percentage of EWL and more durable weight loss results compared with purely restrictive procedures, although at the expense of higher nutritional complications.
Patients undergoing gastric banding and sleeve gastrectomy, primarily restrictive procedures, compare less favorably with RYGB patients in terms of percentage of EWL (40-50% for restrictive surgeries on average) and have a greater risk of weight regain in long-term follow-up. 6, 33, 34 Overall, up to 20% of all bariatric patients lose o50% of their excess weight and are considered surgical failures. The etiology of failed bariatric surgery is complex and most likely multifactorial; contributing factors include technical complications, patient-specific postsurgical eating habits and poor compliance with routine postoperative followup. 35, 36 Attempts at identifying predictors of weight loss failure or regain have been unsuccessful so far. Careful patient selection, preoperative education and meticulous operative technique may contribute to a lower incidence of failure. Clinical research endeavors are focused on identifying clinical, biochemical or molecular factors that may influence bariatric surgery outcomes and therefore have utility as prognostic tools to better select the appropriate procedure for individual patients. Revisional bariatric surgery is an emerging subspecialty in response to the rapid increase in numbers of failed primary bariatric procedures. RYGB is the most commonly practiced revisional bariatric procedure, and has been documented to achieve excellent rescue rates with up to 69% EWL over long-term follow-up. The morbidity and mortality rates for revisional bariatric surgery are higher than those of primary procedures, but are deemed acceptable when considered alongside the restored benefits of weight loss and comorbidity resolution.
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Impact on comorbidities
In addition to substantial weight loss, bariatric surgery is known to have profound metabolic effects, the most striking Surgery for obesity S Eldar et al of which are the marked resolution of obesity-associated comorbidities such as diabetes, hypertension and dyslipidemia. The various procedures differ in the degree of improvement they impart on an obese individual's state of metabolic disarray, with malabsorptive procedures demonstrating greatest benefit in this regard overall. 6 In fact, complete resolution of diabetes is observed in up to 80% of obese diabetic patients undergoing RYGB surgery. 8, 40 The precise mechanisms underlying restoration of euglycemia almost immediately after RYGB remain elusive. Decreased energy intake and loss of metabolically active adipose tissue mass play a paramount role in improving metabolism, yet biochemical indices demonstrate dramatic improvements well in advance of significant weight loss. It is postulated that re-routing the gastrointestinal tract, with exclusion of the duodenum and proximal jejunum, and the rapid transit of undigested nutrients to the distal bowel, alters gut hormone levels including glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), which positively affects insulin and glucose homeostasis. Long-standing diabetes and insulin treatment have been associated with lower resolution rates. 8 Up to 25% of patients with initial resolution of their diabetes have been observed to experience reoccurrence of glucose intolerance and insulin resistance, although this phenomenon has almost always been associated with failure to lose a substantial percentage of EWL primarily or postoperative weight regain. 41 The effects on hypertension and dyslipidemia are similar, with resolution/improvement rates in the range of 60-70% over long-term follow-up. 42 Bariatric surgery positively affects many other morbid conditions that are beyond the scope of this review, including obstructive sleep apnea, gastroesophageal reflux disease, arthritis and back pain, urinary incontinence, gout, thyroid/ parathyroid function, non-alcoholic steatohepatitis, cirrhosis, asthma and others. 43 Impact on cardiovascular risk profile 
Impact on mortality
Several studies have shown that bariatric surgery significantly reduces mortality. The Swedish obese subjects study showed a 30% decrease in mortality rates after 10 years of follow-up, with cancer and myocardial infarction being the leading causes of death. 44 Similar results were reported by Adams et al., 45 showing a 40% reduction in mortality rates, particularly from diabetes, cancer and cardiovascular disease. 40 
Conclusion
It is a striking reflection of the demand for and success of bariatric surgery that annual caseload now matches appendectomy volume. 5, 46 In addition to achieving substantial and durable weight loss, bariatric surgery is associated with favorable metabolic effects far beyond those achieved by lifestyle modifications and pharmacological treatments. Perioperative morbidity and mortality have decreased significantly over the last decade such that bariatric surgery is on par with many well-accepted procedures such as cholecystectomy and hysterectomy. In fact, the 0.3% mortality risk of bariatric surgery is one-tenth that of coronary artery bypass surgery with significantly greater improvement in long-term mortality. Much of the improvement in perioperative morbidity and mortality can be attributed to advances in laparoscopic surgery, as well as establishment of a nation-wide center of excellence network and required outcome reporting. 47 Thus, extensive evidence on safety and efficacy supports bariatric surgery as the standard of care for treatment of severe obesity.
